Journey Medical Corp. (DERM)
7.91
+0.16
(+2.06%)
USD |
NASDAQ |
Aug 24, 16:00
7.75
-0.16
(-2.02%)
Pre-Market: 09:07
Journey Medical Net Income (Quarterly) : -0.312M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.312M |
| March 31, 2026 | -2.23M |
| December 31, 2025 | -1.247M |
| September 30, 2025 | -2.315M |
| June 30, 2025 | -3.796M |
| March 31, 2025 | -4.073M |
| December 31, 2024 | 1.521M |
| September 30, 2024 | -2.39M |
| June 30, 2024 | -3.361M |
| March 31, 2024 | -10.44M |
| December 31, 2023 | -2.143M |
| September 30, 2023 | 16.79M |
| June 30, 2023 | -8.363M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.14M |
| December 31, 2022 | -10.64M |
| September 30, 2022 | -10.08M |
| June 30, 2022 | -7.528M |
| March 31, 2022 | -1.378M |
| December 31, 2021 | -21.75M |
| September 30, 2021 | -10.65M |
| June 30, 2021 | -11.86M |
| March 31, 2021 | 0.268M |
| December 31, 2020 | 2.502M |
| September 30, 2020 | 0.029M |
| June 30, 2020 | 0.455M |
| March 31, 2020 | 2.297M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Nektar Therapeutics | -40.62M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 18.82M |
| EPS Diluted (Quarterly) | -0.0114 |
| Enterprise Value | 218.67M |
| Gross Profit Margin (Quarterly) | 61.58% |
| Profit Margin (Quarterly) | -1.69% |
| Earnings Yield | -2.93% |
| Normalized Earnings Yield | -2.929 |